In a new interview with the Journal of the American Medical Association above, Anthony Fauci, National Institute of Allergy and Infectious Diseases (NAID), said he expects the US will have 100 million doses of a COVID-19 vaccine before the end of the year. “Then, by the beginning of 2021, we hope to have a couple hundred million doses,” he said.
The vaccine in development by Moderna in partnership with the NAID will enter final clinical trials this summer and the company will start cranking out doses at scale before the testing is complete. Meanwhile, several other promising candidates have also been fast-tracked around the world.
“I’m cautiously optimistic that with the multiple candidates we have with different platforms, that we are going to have a vaccine that will make it deployable,” Fauci said.
Read the rest
Fauci said he is a little more concerned about what the durability of the response will be. People develop antibodies to fight common colds caused by other strains of coronavirus, but that protection generally only lasts about a year. That might mean people would need a fresh vaccine every year, as is the case with influenza.
So… remember a few days ago when the World Health Organization declared the Ebola outbreak in the Democratic Republic of Congo as having come to an end. Well, the disease is back on its bullshit again with a brand-new outbreak in the same damn country.
From Al Jazeera:
Four cases of the virus were confirmed in northeastern North Kivu province, the DRC's health minister said in a statement on Wednesday, though there was no indication they were linked to the country's previous - and ninth - Ebola outbreak in northwestern Equateur Province.
"Although we did not expect to face a tenth epidemic so early, the detection of the virus is an indicator of the proper functioning of the surveillance system," Health Minister Oly Ilunga said.
However, it might be impossible to use a vaccine to tackle the new outbreak, Peter Salama, a senior World Health Organization (WHO) official, said.
Yeah, that’s right: the vaccine that worked a miracle this past go-around with Ebola may not be able to do anything for anyone during the latest outbreak of the disease. Experts currently believe that the iteration of Ebola that Congo is currently facing could be one of three strains Zaire, Sudan or Bundibugyo. If it’s the Zaire strain of the disease? Party time: the vaccine developed by Merck should work a treat on it. Unfortunately, if one of the other two possible strains is responsible for the latest outbreak, The WHO admits that there may not be a vaccine option for them to undertake. Read the rest
Last week, officials in charge of stemming the latest outbreak of Ebola virus in the Democratic Republic of Congo began the process of inoculating healthcare workers and other individuals who may have come in direct contact with infect individuals, in the Congolese city of Mbandaka. According to The Globe & Mail, inoculations are now also being doled out in Bikoro, a town in the northwest of Congo, where 5 of the 12 confirmed cases of Ebola are believed to have originated.
It’s believed that there are at least 56 cases of the Ebola: 35 cases have been confirmed, leaving 13 probable cases and 13 suspected cases for doctors to deal with and patients to fret over.
From The Globe & Mail:
Amid worries of the spread of Ebola, several schools in the Iboko health zone, about 180 kilometres (112 miles) southeast of Mbandaka, have been closed, according to reports by U.N.-backed Radio Okapi.
Many residents in one of the Iboko localities told Radio Okapi that they prefer to stay at home to avoid infection, following the death of a woman who had Ebola in the nearby Bobala area.
One resident said that what they first thought were rumours were becoming reality with the death and that they were very scared to interact. Four confirmed Ebola deaths have taken place in the Iboko health zone, according to Congo’s health ministry.
Given that the hemorrhagic fever-causing virus has up to a 90% chance of killing those that it infects, to say that such precautions and the fear that those living in areas where the virus has cropped up during this most recent outbreak are reasonable would be an understatement. Read the rest
The latest Ebola outbreak in Congo has moved from the rural area in which is was first discovered to Mbandaka: a city home to approximately one million people. That the disease has spread to an area with such a dense population is extremely troubling all on its own. Add to this the fact that Mbandaka is a major transportation hub with an airport, river traffic and direct transport options to Kinshasa, Congo's capital city, and you've got a scenario with the potential to keep World Health Organization personnel awake at night.
From the BBC
Forty-two people have now been infected and 23 people are known to have died.
Confirmed, probable and suspected cases of Ebola have been recorded in three health zones of Congo's Equateur province, the World Health Organisation (WHO) said.
The WHO's Peter Salama said health workers had identified 430 people who may have had contact with the disease and were working to trace more than 4,000 contacts of Ebola patients, who had spread across northwest Congo.
As part of efforts to stem the spread of the often deadly disease, drug manufacturer, Merick, shipped 4,000 doses of an unlicensed Ebola vaccine to Congo that was proven to have been effective in a previous outbreak of the disease in West Africa. There's just one problem: the vaccine needs to be stored between -60 and -80 Celsius. In a first world country, that mightn't be an issue--we've the facilities and infrastructure to make chilling the vaccine to those temperatures a piece of cake. Read the rest